GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
95 hedge funds and large institutions have $1.92B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 89 → 95 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
95
Holding in Top 10
1
Calls
$10.8M
Puts
$557K
Top Buyers
| 1 | +$66.6M | |
| 2 | +$46.8M | |
| 3 | +$41.9M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$29.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$24M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$10.5M | |
| 3 | -$8.81M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.82M |
| 5 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$6.85M |